BioCardia (BCDA) News Today $1.85 -0.17 (-8.42%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period BioCardia Reports Q3 2024 Progress and FinancialsNovember 14 at 7:57 PM | markets.businessinsider.comBioCardia’s Strong Q3 Performance and Strategic Trials Drive Buy RatingNovember 14 at 7:57 PM | markets.businessinsider.comBioCardia, Inc. (BCDA) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comBioCardia Reports Third Quarter 2024 Business Highlights and Financial ResultsNovember 13, 2024 | markets.businessinsider.comPromising Outlook for BioCardia with Advancements in CardiAMP HF Program and Personalized Treatment ApproachOctober 29, 2024 | markets.businessinsider.comBioCardia completes last protocol specified follow-up visit in CardiAMP HFOctober 29, 2024 | markets.businessinsider.comBioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart FailureOctober 28, 2024 | markets.businessinsider.comBioCardia Inc (BCDA) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesOctober 9, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Regains Full Compliance with Nasdaq Listing RequirementsSeptember 18, 2024 | finanznachrichten.deBioCardia Regains Full Compliance with Nasdaq Listing RequirementsSeptember 18, 2024 | globenewswire.comBioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq RulesSeptember 9, 2024 | globenewswire.comBioCardia Announces FDA Market Clearance of Morph® DNA(TM) Steerable Introducer Product FamilyAugust 31, 2024 | stockhouse.comWhat In The World Is Going On With UTime (WTO) Stock Today?August 30, 2024 | benzinga.comEnsysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?August 30, 2024 | msn.comWhy BioCardia (BCDA) Stock Is Falling TodayAugust 30, 2024 | msn.comBioCardia Shares Drop 10% After Public Offering PricesAugust 30, 2024 | marketwatch.comBioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq RulesAugust 30, 2024 | tmcnet.comBioCardia, Inc.: BioCardia Announces FDA Market Clearance of Morph DNA Steerable Introducer Product FamilyAugust 29, 2024 | finanznachrichten.deWhy BioCardia (BCDA) Stock Is Up 95% TodayAugust 29, 2024 | msn.comBioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product FamilyAugust 29, 2024 | globenewswire.comStock Market Today: Dow futures rise as Nvidia results drive rotation from megacap techAugust 29, 2024 | marketwatch.comBioCardia, Inc.: FDA Approves CardiAMP Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define TreatmentAugust 21, 2024 | finanznachrichten.deFDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define TreatmentAugust 21, 2024 | globenewswire.comTAL Aug 2024 13.000 callAugust 17, 2024 | ca.finance.yahoo.comTAL Aug 2024 11.000 putAugust 17, 2024 | ca.finance.yahoo.comTAL Aug 2024 8.000 putAugust 17, 2024 | ca.finance.yahoo.comMercer Global Listed Infras A12H0.2700€ (0P0001L5K4.F)August 16, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Reports Second Quarter 2024 Business Highlights and Financial ResultsAugust 14, 2024 | finanznachrichten.deBioCardia Reports Second Quarter 2024 Business Highlights and Financial ResultsAugust 13, 2024 | globenewswire.comBioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product FamilyJuly 30, 2024 | markets.businessinsider.comBuy Rating Affirmed: Promising CardiAMP HF Clinical Trials and CMS Financial Support Signal Strong ProspectsJuly 27, 2024 | markets.businessinsider.comPatient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart FailureJuly 25, 2024 | stockhouse.comBioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal ApplicationJuly 17, 2024 | globenewswire.comBioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery ApproachJune 7, 2024 | globenewswire.comBioCardia, Inc.: BioCardia Announces Reverse Stock SplitMay 22, 2024 | finanznachrichten.deBioCardia Announces Reverse Stock SplitMay 21, 2024 | globenewswire.comBioCardia, Inc. (BCDA)May 18, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsMay 15, 2024 | finanznachrichten.deBioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...May 15, 2024 | finance.yahoo.comBCDA Stock Earnings: BioCardia Reported Results for Q1 2024May 14, 2024 | investorplace.comBioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsMay 14, 2024 | globenewswire.comMost Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is ReasonableMay 14, 2024 | finance.yahoo.comBioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024May 9, 2024 | globenewswire.comBioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesMay 1, 2024 | finance.yahoo.comBioCardia's CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesMay 1, 2024 | globenewswire.comBioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortApril 25, 2024 | globenewswire.comBioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call TranscriptApril 1, 2024 | finance.yahoo.comBioCardia, Inc.: BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsMarch 29, 2024 | finanznachrichten.deBioCardia Full Year 2023 Earnings: Misses ExpectationsMarch 29, 2024 | finance.yahoo.comPreview: BioCardia's EarningsMarch 28, 2024 | benzinga.com Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024's Must-Watch Stocks! (Ad)Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] BCDA Media Mentions By Week BCDA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCDA News Sentiment▼0.730.56▲Average Medical News Sentiment BCDA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCDA Articles This Week▼81▲BCDA Articles Average Week Get BioCardia News Delivered to You Automatically Sign up to receive the latest news and ratings for BCDA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NNVC News CGTX News MEIP News UBX News TNXP News APRE News FNCH News CVKD News CLDI News CARA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCDA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCDA Stock Alerts